Related Experiment Video
Updated: Dec 26, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Compassionate drug use: Current status in India.
Yashashri C Shetty1, Smita Brahma2, P S Manjesh1
1Department of Pharmacology and Therapeutics, Seth Gordhandas Sundardas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India.
Compassionate use (CU) programs offer life-saving experimental treatments to patients with no other options. India
Area of Science:
- Medical Ethics and Drug Regulation
- Pharmaceutical Policy and Access
Background:
- Compassionate Use (CU) provides access to experimental treatments for patients lacking satisfactory authorized therapies or clinical trial eligibility.
- Global regulatory bodies and pharmaceutical companies have increasingly developed robust CU programs in response to patient needs.
- India lacks a formal "Compassionate Use" designation but has existing provisions within the Drugs and Cosmetics Act 1940 and Rules 1945 for drug importation.
Purpose of the Study:
- To examine the current status and regulatory landscape of compassionate use programs in India.
- To highlight the need for enhanced policies and collaborative efforts to expand access to experimental drugs for critically ill patients in India.
Main Methods:
- Analysis of existing Indian drug regulations (Drugs and Cosmetics Act 1940 and Rules 1945) pertaining to drug importation for medical needs.
- Review of documented cases and drug availability (e.g., bedaquiline, delamanid) for specific conditions like extensively drug-resistant tuberculosis (TB) and multidrug-resistant TB.
- Assessment of the current stage of compassionate use implementation in India.
Main Results:
- Applications for drug importation under existing provisions can be submitted by hospitals, patients, or pharmaceutical companies to the Drug Controller General of India.
- The availability of specific drugs for resistant TB demonstrates the practical application of these provisions.
- Compassionate use is currently in its early stages in India due to a lack of specific governing policies and laws.
Conclusions:
- There is a critical need for the development of formal policies and laws to govern compassionate use in India.
- Collaboration between regulatory bodies and pharmaceutical companies is essential to expand the scope of compassionate use for the benefit of patients.
- Strengthening compassionate use frameworks will improve access to potentially life-saving experimental therapies for underserved patient populations in India.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Drug Therapy
Antianxiety Medications
Bioequivalence of Drugs: Drugs with Multiple Indications
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...